Although monoclonal antibodies (mAbs) have long been staples of biotech research and development (R&D), the study of mAb therapeutics has recently attracted a great deal of attention by the pharmac...
No takes yet. Share an insight, caveat, or question.
Janice M. Reichert (2009) studied this question.